Goldman Sachs stays bullish on CVS Caremark (CVS) as it reiterates a Buy rating and tacks on...

|About: CVS Health Corporation (CVS)|By:, SA News Editor

Goldman Sachs stays bullish on CVS Caremark (CVS) as it reiterates a Buy rating and tacks on dollar to lift its price target on shares to $44. Analysts with the firm call CVS a "perfect fit" for large-cap investors on the strength of a "predictable operating algorithm" and solid capital allocation. Shares +0.2% premarket.